SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-07-001688
Filing Date
2007-11-19
Accepted
2007-11-19 13:54:14
Documents
11
Period of Report
2007-11-19

Document Format Files

Seq Description Document Type Size
1 FORM 6-K lorus6k18558.htm 6-K 16182
2 BY-LAW NO. 2 ex991.htm EX-99.1 79578
3 NOTICE OF CHANGE IN CORPORATE STRUCTURE ex992.htm EX-99.2 33685
4 NOTICE ARTICLES OF INCORPORATION ex993.htm EX-99.3 6486
5 GRAPHIC ex993pg1.jpg GRAPHIC 29193
6 GRAPHIC ex993pg2.jpg GRAPHIC 35324
7 GRAPHIC ex993pg3.jpg GRAPHIC 60583
8 GRAPHIC ex993pg4.jpg GRAPHIC 53516
9 GRAPHIC ex993pg5.jpg GRAPHIC 8847
10 GRAPHIC ex993pg6.jpg GRAPHIC 8372
11 GRAPHIC ex993pg7.jpg GRAPHIC 20853
  Complete submission text file 0001279569-07-001688.txt   437091
Mailing Address 2 MERIDIAN ROAD TORONTO A6 M9W 4Z7
Business Address 2 MERIDIAN ROAD . TORONTO A6 M9W 4Z7
LORUS THERAPEUTICS INC (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0531
Type: 6-K | Act: 34 | File No.: 001-32001 | Film No.: 071255726
SIC: 2836 Biological Products, (No Diagnostic Substances)